Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,069 | 672 | 98.7% |
| Education | $130.83 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,544 | 150 | $0 (2022) |
| Novo Nordisk Inc | $1,483 | 117 | $0 (2022) |
| Astellas Pharma US Inc | $861.32 | 49 | $0 (2022) |
| Amgen Inc. | $798.11 | 42 | $0 (2022) |
| PFIZER INC. | $727.37 | 44 | $0 (2022) |
| ABBVIE INC. | $656.35 | 46 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $519.47 | 31 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $441.83 | 10 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $422.79 | 19 | $0 (2021) |
| Lilly USA, LLC | $348.42 | 21 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.48 | 1 | ABBVIE INC. ($32.48) |
| 2023 | $21.10 | 1 | AbbVie Inc. ($21.10) |
| 2022 | $435.13 | 30 | GlaxoSmithKline, LLC. ($151.80) |
| 2021 | $1,786 | 116 | AbbVie Inc. ($313.10) |
| 2020 | $2,226 | 130 | Novo Nordisk Inc ($580.92) |
| 2019 | $1,672 | 121 | GlaxoSmithKline, LLC. ($365.94) |
| 2018 | $1,968 | 141 | Novo Nordisk Inc ($463.10) |
| 2017 | $2,059 | 136 | Novo Nordisk Inc ($261.25) |
All Payment Transactions
676 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Inflammation | ||||||
| 05/25/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes Care | ||||||
| 05/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Diabetes | ||||||
| 04/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.82 | General |
| Category: RESPIRATORY | ||||||
| 03/30/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/28/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Diabetes Care | ||||||
| 03/28/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Inflammation | ||||||
| 03/21/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: PSYCHIATRY | ||||||
| 03/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/02/2022 | Almatica Pharma LLC | GRALISE (Drug), SERTRALINE HCL, LOREEV XR | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 03/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/24/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: Cardiovascular | ||||||
| 02/22/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: PSYCHIATRY | ||||||
| 02/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: RESPIRATORY | ||||||
| 02/17/2022 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: VACCINES | ||||||
| 02/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.52 | General |
| Category: RESPIRATORY | ||||||
| 02/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 47 | 47 | $4,806 | $3,214 |
| 2022 | 6 | 643 | 717 | $102,772 | $56,082 |
| 2021 | 16 | 1,882 | 2,672 | $343,651 | $217,258 |
| 2020 | 12 | 1,496 | 2,403 | $337,810 | $184,140 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $1,795 | $1,390 | 77.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 11 | 11 | $1,171 | $897.38 | 76.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $1,591 | $731.33 | 46.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $248.82 | $195.69 | 78.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 330 | 400 | $57,156 | $28,188 | 49.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 129 | 129 | $22,121 | $16,543 | 74.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 50 | 51 | $11,425 | $5,846 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 63 | $6,954 | $2,368 | 34.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 15 | $3,768 | $2,069 | 54.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 59 | 59 | $1,349 | $1,066 | 79.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 554 | 1,096 | $153,445 | $94,932 | 61.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 416 | 416 | $83,200 | $54,958 | 66.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 352 | 569 | $56,941 | $36,451 | 64.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 61 | 73 | $17,520 | $11,500 | 65.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $7,010 | $4,319 | 61.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 219 | 219 | $5,275 | $4,006 | 75.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 29 | 31 | $5,580 | $3,940 | 70.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 13 | 13 | $2,600 | $2,180 | 83.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 45 | 46 | $3,872 | $1,849 | 47.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 28 | 29 | $2,320 | $922.39 | 39.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $2,280 | $685.13 | 30.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 11 | 14 | $910.00 | $456.12 | 50.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 42 | 42 | $840.00 | $447.15 | 53.2% |
| 69209 | Removal of impacted ear wax by washing | Office | 2021 | 21 | 23 | $690.00 | $333.39 | 48.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 21 | $617.72 | $201.60 | 32.6% |
About Dr. Don Alfonso, M.D
Dr. Don Alfonso, M.D is a Specialist healthcare provider based in Palm Coast, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073508917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Don Alfonso, M.D has received a total of $10,200 in payments from pharmaceutical and medical device companies, with $32.48 received in 2024. These payments were reported across 676 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($10,069).
As a Medicare-enrolled provider, Alfonso has provided services to 4,068 Medicare beneficiaries, totaling 5,839 services with total Medicare billing of $460,694. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Palm Coast, FL
- Active Since 09/16/2005
- Last Updated 01/29/2010
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1073508917
Products in Payments
- TRELEGY ELLIPTA (Drug) $963.21
- MYRBETRIQ (Drug) $618.09
- Ozempic (Drug) $509.82
- Victoza (Drug) $486.28
- XARELTO (Drug) $427.87
- FARXIGA (Drug) $395.24
- JARDIANCE (Drug) $360.70
- LINZESS (Drug) $342.84
- Prolia (Biological) $292.60
- ENTRESTO (Drug) $248.71
- ANORO (Drug) $238.93
- UBRELVY (Drug) $203.96
- VRAYLAR (Drug) $182.59
- EVENITY (Biological) $177.66
- TOUJEO (Drug) $172.87
- CHANTIX (Drug) $168.84
- ELIQUIS (Drug) $159.17
- TRULICITY (Drug) $154.12
- COLOGUARD (Device) $144.95
- Myrbetriq (Drug) $143.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Palm Coast
Dr. Renato Alfonso, M.d, M.D
Specialist — Payments: $14,142
Dr. Jerry Leventhal, M.d, M.D
Specialist — Payments: $12,638
Dr. Alvaro Alvarez-Farinetti, M.d, M.D
Specialist — Payments: $7,572
Dennis Alter, Md, MD
Specialist — Payments: $4,856
Santiago Calderon Perez, Md, MD
Specialist — Payments: $1,049
Dr. Angela Schnell, Dpt, DPT
Specialist — Payments: $85.04